-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Emergent BioSolutions Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$204M, a 30.5% increase year-over-year.
- Emergent BioSolutions Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$450M, a 16.9% increase year-over-year.
- Emergent BioSolutions Inc. annual Operating Income (Loss) for 2023 was -$726M, a 327% decline from 2022.
- Emergent BioSolutions Inc. annual Operating Income (Loss) for 2022 was -$170M, a 150% decline from 2021.
- Emergent BioSolutions Inc. annual Operating Income (Loss) for 2021 was $341M, a 22.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)